ArticleAnnals of the rheumatic diseases2003

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

D Baeten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.